Skip to main content
. Author manuscript; available in PMC: 2016 Jul 30.
Published in final edited form as: Neuroepidemiology. 2015 Jul 30;45(1):59–69. doi: 10.1159/000437228

Table 2.

Group Comparisons

Group Controls
N=196
PDD
N=388
SWEDD
N=64

Age at baseline(years) 60.8 (11.2) 61.5 (9.79) 61.0 (10.0)

Age of onset 59.6 (10.0) 58.8 (10.5)

Sex (N (%women)) 70 (35.7%) 132 (34.0%) 24 (37.5%)

Time from first symptom to baseline visit (months) 22.7 (23.7) 23.5 (27.5)

Time from first symptom to diagnosis (months) 17.1 (22.2) 18.6 (26.3)

Total Years of Education 16.0 (2.89) 15.6 (3.00) 15.1 (3.87)

Non-motor measures

MDS Non Motor Pt 1 1,2 2.92 (2.97) 5.55 (4.05) 8.25 (6.47)

UPSIT1,2 34.0 (4.85) 22.3 (8.28) 31.4 (6.23)

SCOPA-AUTO1,2 8.88 (7.43) 13.4 (9.55) 17.2 (12.2)

Cognitive Measures

Benton Line Judgement 13.1 (1.98) 12.8 (2.12) 12.8 (2.38)

Hopkins verbal learning 2 15.6 (2.29) 14.7 (2.59) 14.4 (2.55)

Letter number sequence 3 10.9 (2.57) 10.6 (2.66) 9.88 (2.66)

Montreal Cognitive Assessment Battery2 28.2 (1.11) 27.2 (2.33) 27.1 (2.44)

Semantic Fluency 2 51.8 (11.2) 48.9 (11.7) 45.2 (12.4)

Symbol Digit2 46.8 (10.5) 41.3 (9.87) 41.2 (11.9)

Sleep-related Measures

REM2 2.85 (2.26) 4.13 (2.68) 4.55 (2.86)

Epworth Sleepiness1 5.64 (3.42) 5.83 (3.46) 8.08 (4.80)

Psychiatric Measures

Presence of Impulsive/Compulsive behaviors1 36 (18.7%) 77 (19.8%) 21 (32.8%)

Depression 5.18 (1.38) 5.27 (1.45) 5.64 (1.71)

Anxiety State and Trait 47.0 (3.50) 46.6 (3.88) 46.6 (3.83)

Motor Measures

Posture/Gait score1,2 0.04 (0.10) 0.34 (0.28) 0.21 (0.31)

Hypokinesia/Rigidity score1,2 0.04 (0.08) 0.80 (0.41) 0.48 (0.43)

Tremor score2 0.03 (0.08) 0.43 (0.31) 0.44 (0.29)

Motor Feature present at dx (N (% of group)):
Tremor 0 301 (77.6%) 53 (84.1%)
Rigidity4 0 298 (76.8%) 37 (58.7%)
Bradykinesia 0 321 (82.7%) 51 (81.0%)
Postural Instability 0 26 (6.70%) 8 (12.9%)
Asymmetry of motor features4
Left side more affected 0 166 (42.8%) 15 (23.4%)
Right side more affected 0 212 (54.6%) 44 (68.8%)
Both sides equally affected 0 10 (2.58%) 5 (7.81%)

NHY (Hoehn and Yahr Stage)2 0 1.55 (0.51) 1.42 (0.50)

Neuroimaging

DATScan
R Caudate4,5 2.98 (0.62) 1.99 (0.58) 2.81 (0.60)
L Caudate4,5 3.03 (0.64) 1.99 (0.57) 2.82 (0.58)
R Putamen4,5 2.17 (0.61) 0.86 (0.37) 2.07 (0.52)
L Putamen4,5 2.16 (0.59) 0.83 (0.36) 2.03 (0.52)

SWEDD=Scans without evidence of dopaminergic deficits

Please refer to Table 1 for Legend. Unless noted, all values in parentheses are standard deviations of raw scores.

1

SWEDD group is significantly different from Control and PDD groups

2

Control group is significantly different from SWEDD and PDD groups

3

SWEDD group is significantly different from Control group but not from PDD group

4

PDD group is significantly different from SWEDD group but not controls

5

Control group is significantly different from PDD group but not SWEDD group